Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Triglyceride-Glucose Index and TGI-BMI for Insulin Resistance Assessment: A Comparative Study With HOMA-IR

NCT07260201 is registered in ClinicalTrials.gov with Hisar Intercontinental Hospital as lead sponsor.

NCT NCT07260201
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07260201 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Triglyceride-Glucose Index and TGI-BMI for Insulin Resistance Assessment: A Comparative Study With HOMA-IR
Lead sponsor
Hisar Intercontinental Hospital
Phase
Observational
Overall status
Completed
Start date
December 1, 2024
Completion date
October 27, 2025
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insulin resistance, obesity type 2 diabetes mellitus